EXAS - CIK 0001124140
EXACT SCIENCES CORP (EXAS) reported net income of -$207.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$207.95M | +79.8% |
| FY 2024 | -$1.03B | -404.0% |
| FY 2023 | -$204.15M | +67.3% |
| FY 2022 | -$623.51M | -4.7% |
| FY 2021 | -$595.63M | +27.7% |
| FY 2020 | -$823.61M | -286.5% |
| FY 2019 | -$213.09M | -21.7% |
| FY 2018 | -$175.15M | -53.1% |
| FY 2017 |
EXACT SCIENCES CORP (EXAS) reported net income of -$207.95M for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2015 and fiscal 2025, EXACT SCIENCES CORP's net income declined from -$157.80M to -$207.95M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| -$114.40M |
| +31.6% |
| FY 2016 | -$167.21M | -6.0% |
| FY 2015 | -$157.80M | - |